Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Cabaletta Bio, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 159 | 1 | 142 | −16 |
| Shares | 51.1M | 33.4K | 50.8M | −215.5K (−0.4%) |
| Value | $870.9M | $569.6K | $380.0M | −$490.4M (−56.3%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Cabaletta Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exome Asset Management LLC | 300,200 | $2.25M | 2.00% |
| Panagora Asset Management Inc | 299,801 | $2.24M | 0.01% |
| Walleye Capital LLC | 189,957 | $1.42M | 0.01% |
| Jump Financial, LLC | 182,135 | $1.36M | 0.03% |
| Prelude Capital Management, LLC | 95,200 | $712.1K | 0.06% |
| Two Sigma Advisers, LP | 72,500 | $542.3K | 0.00% |
| Verition Fund Management LLC | 57,626 | $431.0K | 0.00% |
| Corton Capital Inc. | 31,931 | $238.8K | 0.13% |
| Aquatic Capital Management LLC | 31,100 | $232.6K | 0.01% |
| Corebridge Financial, Inc. | 23,129 | $173.0K | 0.00% |
| Nomura Holdings Inc | 23,057 | $172.5K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 21,797 | $162.5K | 0.00% |
| Group One Trading, L.P. | 20,669 | $154.6K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 18,727 | $140.1K | 0.01% |
| Capstone Investment Advisors, LLC | 17,245 | $129.0K | 0.00% |
| Bridgefront Capital, LLC | 11,876 | $88.8K | 0.04% |
| Simplex Trading, LLC | 6,204 | $46.0K | 0.00% |
| Quarry LP | 207 | $1.55K | 0.00% |
| EverSource Wealth Advisors, LLC | 72 | $511 | 0.00% |
Sold out (35)
Institutions that held Cabaletta Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Cabaletta Bio, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 33,388 | $569.6K |